As we continue to learn more about the novel coronavirus and COVID-19, we’re also learning more about COVID-19 testing: Who should get tested, and when? How accurate are the tests? In this webinar, hosted by NHTSA’s Office of EMS, you’ll learn:

– The local experience of some of the first EMS systems to have personnel quarantined and test positive for COVID-19
– The latest guidance on testing of first responders and other healthcare personnel
– What the result of a COVID-19 test or antibody test really means for individuals and EMS organizations

Three panelists deeply involved in the EMS and public health response to COVID-19 share their expertise:

– Jonathan Jui, MD, MPH, FACEP, is EMS medical director for Multnomah County, Oregon, including the City of Portland and the county 911 center. He is also a member of the Oregon 2 Disaster Medical Assistance Team and a professor of emergency medicine at Oregon Health & Science University. Dr. Jui is board certified in emergency medicine, internal medicine, EMS, and infectious disease.

– Michael Sayre, MD, is medical director for the Seattle Fire Department and the Seattle Medic One program and an emergency physician at Harborview Medical Center. He is a professor of emergency medicine at the University of Washington, where he also serves as the medical director for the Michael K. Copass Paramedic Training Program and leads the EMS Medicine Fellowship program.

– S. Michele Owen, PhD, is associate director for laboratory science at the US Centers for Disease Control and Prevention’s National Center for HIV/AIDS, Viral Hepatitis, STD and TB prevention. She is also currently serving as Co-Lead for the COVID-19 Laboratory Task Force in the CDC Incident Management Structure.

The webinar is moderated by Jon Krohmer, MD, FACEP, FAEMS, director of the NHTSA Office of EMS and co-chair of the EMS/Pre-hospital Team within the FEMA Healthcare Resilience Task, which is leading the development of a comprehensive strategy for the US healthcare system to facilitate resiliency and responsiveness to the threats posed by COVID-19.